Nomura Holdings
EDIT icon

Nomura Holdings’s Editas Medicine EDIT Stock Holding History

Nomura Holdings’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-53,444
Closed -$474K – 1535
2022
Q4 		$474K Buy
53,444
+16,500
+45% +$181K ﹤0.01% 986
2022
Q3 		$452K Hold
36,944
– – ﹤0.01% 1123
2022
Q2 		$465K Buy
36,944
+17,444
+89% +$234K ﹤0.01% 1135
2022
Q1 		$394K Buy
19,500
+8,989
+86% +$167K ﹤0.01% 1372
2021
Q4 		$279K Buy
+10,511
New +$362K ﹤0.01% 1696
2021
Q3 		– Sell
-6,250
Closed -$355K – 2049
2021
Q2 		$355K Sell
6,250
-1,000
-14% -$36.9K ﹤0.01% 1523
2021
Q1 		$304K Buy
+7,250
New +$413K ﹤0.01% 1500

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Nomura Holdings's EDIT Position: Q1 2023 in Review

Nomura Holdings sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 53,444 shares — an estimated $474K sold.

Nomura Holdings first reported a position in EDIT in Q1 2021 and held it in 7 quarters. The position peaked at $474K in Q4 2022. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Nomura Holdings reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • Nomura Holdings sold 53,444 Editas Medicine shares in Q1 2023, an estimated $474K.
  • Nomura Holdings first reported a position in Editas Medicine in Q1 2021 and held it in 7 quarters.
  • Nomura Holdings's Editas Medicine position peaked at $474K in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.